title: [Selective internal radiotherapy (SIRT) of liver tumors].
abstract: METHODS
  Selective internal radiotherapy (SIRT) is a safe and efficacious, minimally invasive procedure to treat primary and secondary unresectable liver tumors. For hepatocellular carcinoma (HCC), SIRT has proven to be a well-tolerated therapy option even in advanced stages of disease.
  
  
  METHODS
  In cases of portal vein thrombosis SIRT is the alternative to transarterial chemoembolization (TACE).
  
  
  METHODS
  The role of SIRT regarding downstaging and bridging to transplantation is promising and SIRT has also been shown to be highly effective and well-tolerated in metastastic liver disease.
  
  
  RESULTS
  The results of prospective randomized trials are awaited to prove the efficiency and safety of SIRT described in numerous retrospective and prospective non-randomized studies.
  
  
  CONCLUSIONS
  The indications are established within the framework of a tumor board.
authors.affiliation: Klinische Abteilung für Nuklearmedizin, Universitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien, Wien, Österreich.
authors.forename: H
authors.initials: H
authors.lastname: Duan
authors.forename: M
authors.initials: M
authors.lastname: Hoffmann
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy*; D011868:Radioisotopes / Q000627:therapeutic use*; D061089:Radiotherapy, Image-Guided / Q000379:methods*
chemical_list: D011868:Radioisotopes